164 related articles for article (PubMed ID: 28404918)
21. Intercellular adhesion molecule-1 (ICAM-1) is upregulated in aggressive papillary thyroid carcinoma.
Buitrago D; Keutgen XM; Crowley M; Filicori F; Aldailami H; Hoda R; Liu YF; Hoda RS; Scognamiglio T; Jin M; Fahey TJ; Zarnegar R
Ann Surg Oncol; 2012 Mar; 19(3):973-80. PubMed ID: 21879273
[TBL] [Abstract][Full Text] [Related]
22. Differential expression of mucins 1-6 in papillary thyroid carcinoma: evidence for transformation-dependent post-translational modifications of MUC1 in situ.
Magro G; Schiappacassi M; Perissinotto D; Corsaro A; Borghese C; Belfiore A; Colombatti A; Grasso S; Botti C; Bombardieri E; Perris R
J Pathol; 2003 Jul; 200(3):357-69. PubMed ID: 12845632
[TBL] [Abstract][Full Text] [Related]
23. The expression and role of serum response factor in papillary carcinoma of the thyroid.
Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS
Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551
[TBL] [Abstract][Full Text] [Related]
24. Biological significance of aminopeptidase N/CD13 in thyroid carcinomas.
Kehlen A; Lendeckel U; Dralle H; Langner J; Hoang-Vu C
Cancer Res; 2003 Dec; 63(23):8500-6. PubMed ID: 14679016
[TBL] [Abstract][Full Text] [Related]
25. The Role of Notch1 Signaling in Anaplastic Thyroid Carcinoma.
Kim HJ; Kim MJ; Kim A; Jung CW; Park S; Koh JS; Myung JK
Cancer Res Treat; 2017 Apr; 49(2):509-517. PubMed ID: 27586674
[TBL] [Abstract][Full Text] [Related]
26. Plasma alpha-L-fucosidase activity in chronic inflammation and autoimmune disorders in a pediatric cohort of hospitalized patients.
Endreffy I; Bjørklund G; Szerafin L; Chirumbolo S; Urbina MA; Endreffy E
Immunol Res; 2017 Oct; 65(5):1025-1030. PubMed ID: 28808940
[TBL] [Abstract][Full Text] [Related]
27. Tumor-microenvironment interactions: the fucose-generating FX enzyme controls adhesive properties of colorectal cancer cells.
Zipin A; Israeli-Amit M; Meshel T; Sagi-Assif O; Yron I; Lifshitz V; Bacharach E; Smorodinsky NI; Many A; Czernilofsky PA; Morton DL; Witz IP
Cancer Res; 2004 Sep; 64(18):6571-8. PubMed ID: 15374970
[TBL] [Abstract][Full Text] [Related]
28. Expression study of an alpha-l-fucosidase gene in the Drosophilidae family.
Pasini ME; Intra J; Pavesi G
Gene; 2008 Aug; 420(1):23-33. PubMed ID: 18556148
[TBL] [Abstract][Full Text] [Related]
29. Integrated Analysis of Thyroid Cancer Public Datasets Reveals Role of Post-Transcriptional Regulation on Tumor Progression by Targeting of Immune System Mediators.
Geraldo MV; Kimura ET
PLoS One; 2015; 10(11):e0141726. PubMed ID: 26536459
[TBL] [Abstract][Full Text] [Related]
30. Quantitative measurement of telomerase reverse transcriptase, thyroglobulin and thyroid transcription factor 1 mRNAs in anaplastic thyroid carcinoma tissues and cell lines.
Takano T; Ito Y; Matsuzuka F; Miya A; Kobayashi K; Yoshida H; Miyauchi A
Oncol Rep; 2007 Sep; 18(3):715-20. PubMed ID: 17671725
[TBL] [Abstract][Full Text] [Related]
31. Differential pattern of integrin receptor expression in differentiated and anaplastic thyroid cancer cell lines.
Hoffmann S; Maschuw K; Hassan I; Reckzeh B; Wunderlich A; Lingelbach S; Zielke A
Thyroid; 2005 Sep; 15(9):1011-20. PubMed ID: 16187909
[TBL] [Abstract][Full Text] [Related]
32. [Pathological study on the expression of cell adhesion molecules and metastasis suppressor gene in thyroid follicular carcinoma and papillary carcinoma].
Liu Y; Jiang C; Tan Y
Zhonghua Bing Li Xue Za Zhi; 2002 Aug; 31(4):322-6. PubMed ID: 12417089
[TBL] [Abstract][Full Text] [Related]
33. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
[TBL] [Abstract][Full Text] [Related]
34. Identification of a mutation in the structural alpha-L-fucosidase gene in fucosidosis.
Willems PJ; Darby JK; DiCioccio RA; Nakashima P; Eng C; Kretz KA; Cavalli-Sforza LL; Shooter EM; O'Brien JS
Am J Hum Genet; 1988 Nov; 43(5):756-63. PubMed ID: 2903668
[TBL] [Abstract][Full Text] [Related]
35. ZNRF3 is downregulated in papillary thyroid carcinoma and suppresses the proliferation and invasion of papillary thyroid cancer cells.
Qiu W; Yang Z; Fan Y; Zheng Q
Tumour Biol; 2016 Sep; 37(9):12665-12672. PubMed ID: 27448298
[TBL] [Abstract][Full Text] [Related]
36. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma.
Chou CK; Yang KD; Chou FF; Huang CC; Lan YW; Lee YF; Kang HY; Liu RT
J Clin Endocrinol Metab; 2013 Feb; 98(2):E196-205. PubMed ID: 23264400
[TBL] [Abstract][Full Text] [Related]
37. RNA interference targeting CD147 inhibits the proliferation, invasiveness, and metastatic activity of thyroid carcinoma cells by down-regulating glycolysis.
Huang P; Chang S; Jiang X; Su J; Dong C; Liu X; Yuan Z; Zhang Z; Liao H
Int J Clin Exp Pathol; 2015; 8(1):309-18. PubMed ID: 25755717
[TBL] [Abstract][Full Text] [Related]
38. [Corrigendum] FUCA1 is induced by wild-type p53 and expressed at different levels in thyroid cancers depending on p53 status.
Int J Oncol; 2017 Sep; 51(3):996-0. PubMed ID: 28731163
[TBL] [Abstract][Full Text] [Related]
39. MiR-125b inhibits anaplastic thyroid cancer cell migration and invasion by targeting PIK3CD.
Bu Q; You F; Pan G; Yuan Q; Cui T; Hao L; Zhang J
Biomed Pharmacother; 2017 Apr; 88():443-448. PubMed ID: 28122310
[TBL] [Abstract][Full Text] [Related]
40. The role of podoplanin in the biology of differentiated thyroid cancers.
Rudzińska M; Gaweł D; Sikorska J; Karpińska KM; Kiedrowski M; Stępień T; Marchlewska M; Czarnocka B
PLoS One; 2014; 9(5):e96541. PubMed ID: 24797369
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
